Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics Patients
Bastien Genet, Jean‐Sébastien Vidal, Adrien Cohen, et al.
Journal of the American Medical Directors Association (2020) Vol. 21, Iss. 11, pp. 1539-1545
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis
Benedetta Vai, Mario Gennaro Mazza, Claudia Colli, et al.
The Lancet Psychiatry (2021) Vol. 8, Iss. 9, pp. 797-812
Open Access | Times Cited: 271
Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases
George El-Arif, Shaymaa Khazaal, Antonella Farhat, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2048-2048
Open Access | Times Cited: 71
Chronic Diseases as a Predictor for Severity and Mortality of COVID-19: A Systematic Review With Cumulative Meta-Analysis
Jinsong Geng, Xiaolan Yu, Haini Bao, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 83
Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019
Jordan Swiderski, Laura Kate Gadanec, Vasso Apostolopoulos, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 787-787
Open Access | Times Cited: 21
Dementia as a mortality predictor among older adults with COVID-19: A systematic review and meta-analysis of observational study
Ita Daryanti Saragih, Ice Septriani Saragih, Sakti Oktaria Batubara, et al.
Geriatric Nursing (2021) Vol. 42, Iss. 5, pp. 1230-1239
Open Access | Times Cited: 42
Mortality and Severity in COVID-19 Patients on ACEIs and ARBs—A Systematic Review, Meta-Analysis, and Meta-Regression Analysis
Romil Singh, Sawai Singh Rathore, Hira Khan, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 28
A Meta-Analysis of the Impact of Using Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin II Receptor Blockers (ARBs) on Mortality, Severity, and Healthcare Resource Utilization in Patients with COVID-19
Ruijuan Li, Jie Zhang, Liang Ren
Advances in respiratory medicine (2025) Vol. 93, Iss. 1, pp. 4-4
Open Access
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor
Murat Öz, Dietrich E. Lorke, Nadine Kabbani
Pharmacology & Therapeutics (2020) Vol. 221, pp. 107750-107750
Open Access | Times Cited: 41
SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: systematic review with frequentist and Bayesian meta-analyses
Muhannad Smadi, Melina Kaburis, Youval Schnapper, et al.
The British Journal of Psychiatry (2023) Vol. 223, Iss. 2, pp. 348-361
Open Access | Times Cited: 14
Association of calcium channel blocker use with clinical outcome of COVID-19: A meta-analysis
Mochamad Yusuf Alsagaff, Eka Prasetya Budi Mulia, Irma Maghfirah, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 5, pp. 102210-102210
Open Access | Times Cited: 30
Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
Jordan Loader, Frances C. Taylor, Erik Lampa, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 11
Open Access | Times Cited: 19
Charlson comorbidity index, neutrophil-to-lymphocyte ratio and undertreatment with renin-angiotensin-aldosterone system inhibitors predict in-hospital mortality of hospitalized COVID-19 patients during the omicron dominant period
Andrea Sonaglioni, Michele Lombardo, Adriana Albini, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Proton pump inhibitor on susceptibility to COVID-19 and its severity: a systematic review and meta-analysis
Raymond Pranata, Ian Huang, Sherly Lawrensia, et al.
Pharmacological Reports (2021) Vol. 73, Iss. 6, pp. 1642-1649
Open Access | Times Cited: 26
Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis
Abraham Degarege, Zaeema Naveed, Josiane Kabayundo, et al.
Pathogens (2022) Vol. 11, Iss. 5, pp. 563-563
Open Access | Times Cited: 17
Cardiovascular, Pulmonary, and Neuropsychiatric Short- and Long-Term Complications of COVID-19
Małgorzata Kobusiak−Prokopowicz, Katarzyna Fułek, Michał Fułek, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3882-3882
Open Access | Times Cited: 16
Classical and Counter-Regulatory Renin–Angiotensin System: Potential Key Roles in COVID-19 Pathophysiology
Moudhi Almutlaq, Abir Alamro, Fayhan Alroqi, et al.
CJC Open (2021) Vol. 3, Iss. 8, pp. 1060-1074
Open Access | Times Cited: 17
The Interplay Between the Immune System, the Renin‐Angiotensin‐Aldosterone System (RAAS), and RAAS Inhibitors May Modulate the Outcome of COVID‐19: A Systematic Review
Hiba Naveed, Abdallah Elshafeey, Dana Al‐Ali, et al.
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. 8, pp. 987-1000
Open Access | Times Cited: 13
Long-term oral ACEI/ARB therapy is associated with disease severity in elderly COVID-19 omicron BA.2 patients with hypertension
Zhe Zhang, Sheng Wu, Z. Wang, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Renin‐Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID‐19
Jordan Loader, Erik Lampa, Stefan Gustafsson, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 15
Open Access | Times Cited: 11
Impact of hypertension on long-term humoral and cellular response to SARS-CoV-2 infection
Chang Chu, Anne Schönbrunn, Kristin Klemm, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
A nationwide cohort study of the association of benzodiazepines with SARS-CoV-2 infection and clinical outcomes
Hye Yoon Park, Junhyun Kwon, Suk Kyoon An, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Mortality and Severity in COVID-19 Patients on ACEIs & ARBs - A Meta-Regression Analysis
Romil Singh, Sawai Singh Rathore, Hira Khan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
Update Alert 7: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults
Katherine Mackey, Devan Kansagara, Kathryn Vela
Annals of Internal Medicine (2021) Vol. 174, Iss. 2, pp. W25-W29
Open Access | Times Cited: 9
The effects of antihypertensive medications on severity and outcomes of hypertensive patients with COVID-19
Samira Nakhaie, Rostam Yazdani, M R Shakibi, et al.
Journal of Human Hypertension (2022) Vol. 37, Iss. 7, pp. 511-518
Open Access | Times Cited: 6
Drugs acting on the renin–angiotensin–aldosterone system (RAAS) and deaths of COVID-19 patients: a systematic review and meta-analysis of observational studies
Ruchika Sharma, Anoop Kumar, Jaseela Majeed, et al.
The Egyptian Heart Journal (2022) Vol. 74, Iss. 1
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top